Literature DB >> 18769333

Extracapsular penetration is a new prognostic factor in human hepatocellular carcinoma.

Tomohiro Iguchi1, Shinichi Aishima, Akinobu Taketomi, Yunosuke Nishihara, Nobuhiro Fujita, Kensaku Sanefuji, Yoshihiko Maehara, Masazumi Tsuneyoshi.   

Abstract

The fibrous capsule is a unique characteristic of hepatocellular carcinoma (HCC) and acts as a barricade preventing the spread of cancer cells. Infiltration to the capsule (fc-inf) is the invasive feature in HCC; however, there are no reports of a detailed investigation regarding fc-inf. We selected 88 HCCs of <or=5 cm in diameter, when considered together with both the single nodular and the single nodular with extranodular growth types. We classified the infiltrating pattern into 2 types: extracapsular (EC) infiltrating type (n=38), in which cancer cells infiltrated outside the capsule and touched the existing liver parenchyma, and intracapsular (IC) infiltrating type (n=50), in which the infiltrating cancer cells stayed inside the capsule. The distance of infiltration and the capsular thickness were measured and the ratio of capsular infiltration (CI index) was calculated. There were no clinicopathologic differences between the 2 types, but the capsular thickness of IC type was greater than that of EC type (P<0.0001). EC type showed a poorer outcome for the overall survival and the disease-free survival (P=0.0210 and P=0.0115, respectively) and EC type was an independent prognostic factor for a disease-free survival (P=0.0158). However, CI index did not correlate with any clinicopathologic factors or the patient prognosis in IC type. We propose a new definition of fc-inf as a histologic feature of cancer cells penetrating to the liver parenchyma through the fibrous capsule. It may be closely related to the patient prognosis and may therefore, become a new and useful pathologic factor.

Entities:  

Mesh:

Year:  2008        PMID: 18769333     DOI: 10.1097/PAS.0b013e31817a8ed5

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  9 in total

Review 1.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.

Authors:  Jin-Young Choi; Jeong-Min Lee; Claude B Sirlin
Journal:  Radiology       Date:  2014-09       Impact factor: 11.105

Review 2.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features.

Authors:  Jin-Young Choi; Jeong-Min Lee; Claude B Sirlin
Journal:  Radiology       Date:  2014-10       Impact factor: 11.105

3.  Radiomic Features of Multi-ROI and Multi-Phase MRI for the Prediction of Microvascular Invasion in Solitary Hepatocellular Carcinoma.

Authors:  Yan Yang; WeiJie Fan; Tao Gu; Li Yu; HaiLing Chen; YangFan Lv; Huan Liu; GuangXian Wang; Dong Zhang
Journal:  Front Oncol       Date:  2021-10-07       Impact factor: 6.244

4.  Long-Term Survival Impact of High-Grade Complications after Liver Resection for Hepatocellular Carcinoma: A Retrospective Single-Centre Cohort Study.

Authors:  Chin-Wen Kuo; Hsiang-Ling Wu; Chun-Cheng Li; Juan P Cata; Hsin-Yi Liu; Ming-Chih Hou; Yih-Giun Cherng; Ying-Hsuan Tai
Journal:  Medicina (Kaunas)       Date:  2022-04-12       Impact factor: 2.430

5.  Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma.

Authors:  Gang Zhao; Zi-ming Huang; Ya-Lin Kong; Dong-Qing Wen; Yu Li; Li Ren; Hong-Yi Zhang
Journal:  World J Surg Oncol       Date:  2013-03-21       Impact factor: 2.754

6.  Biological and Prognostic Significance of the Morphological Types and Vascular Patterns in Colorectal Liver Metastases (CRLM): Looking Beyond the Tumor Margin.

Authors:  Pulathis N Siriwardana; Tu Vinh Luong; Jennifer Watkins; Helen Turley; Mohamed Ghazaley; Kevin Gatter; Adrian L Harris; Daniel Hochhauser; Brian R Davidson
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

7.  Positive expression of ZNF689 indicates poor prognosis of hepatocellular carcinoma.

Authors:  Peng Sheng Yi; Bin Wu; Da Wei Deng; Guang Nian Zhang; Jian Shui Li
Journal:  Oncol Lett       Date:  2018-08-10       Impact factor: 2.967

8.  Factors influencing early recurrence of hepatocellular carcinoma after curative resection.

Authors:  Yu Zhu; Lingling Gu; Ting Chen; Guoqun Zheng; Chao Ye; Weidong Jia
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

9.  From LI-RADS Classification to HCC Pathology: A Retrospective Single-Institution Analysis of Clinico-Pathological Features Affecting Oncological Outcomes after Curative Surgery.

Authors:  Leonardo Centonze; Riccardo De Carlis; Ivan Vella; Luca Carbonaro; Niccolò Incarbone; Livia Palmieri; Cristiano Sgrazzutti; Alberto Ficarelli; Maria Grazia Valsecchi; Umberto Dello Iacono; Andrea Lauterio; Davide Bernasconi; Angelo Vanzulli; Luciano De Carlis
Journal:  Diagnostics (Basel)       Date:  2022-01-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.